Imalux® Corporation and Preventive Oncology International®, Inc. Differentiate Grades of Pre-Invasive Cervical Dysplasia with Niris Optical Coherence Tomography Imaging System (February 24, 2009)
Imalux® Corporation and Preventive Oncology International®, Inc. Differentiate Grades of Pre-Invasive Cervical Dysplasia with Niris Optical Coherence Tomography Imaging System (February 24, 2009)
Imalux Collaborates Again with Preventative Oncology International™ in Second Study of Cervical Cancer in China (May 16, 2008)
Imalux Collaborates with Preventative Oncology International™ in Study of Cervical Cancer in China (January 10, 2008)
Imalux Awarded $2.3 Million Research Grant (November 5, 2007)
Imalux Closes Series C Funding Round (September 26, 2007)
Imalux Announces Major European Clinical Trials (April 26, 2007)
Imalux Corporation To Hold “Applications of Optical Coherence Tomography (OCT) Technology in Urology” Post Graduate Session At World Congress of Endourolgy (August 8, 2006)
Congresswoman Stephanie Tubbs Jones to Review The Niris™ Imaging System During Visit to Imalux Corporation (April 10, 2006)
Imalux Commences Australia and New Zealand Market Development Activity – Set to Make First Shipments (March 16, 2006)
Imalux Introduces Niris™ Imaging System at AUA 2005 (April 19, 2005)
Imalux Introduces Niris™ Imaging System at DDW 2005 (April 15, 2005)
Imalux Introduces OCT Imaging System – Partners with Optiphase for Manufacture of Key Imaging System Component (January 22, 2005)
Imalux Closes Series B Funding Round (January 6, 2005)
Imalux Corporation Receives Final FDA Clearance to Market the Niris™ Imaging System (January 3, 2005)
Imalux Receives Funding, FDA Clearance (August 23, 2004)
Imalux Completes Common Stock Offering (March 19, 2004)
Imalux Corporation Receives FDA Clearance for OCT Imaging Device (March 5, 2004)
Imalux Completes $3.5 Million Financing (September 22, 2003)
Imalux closes next round of investment (October 31, 2002)
